Janney Montgomery Scott’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,775
Closed -$2.07M 2768
2025
Q4
$2.07M Sell
11,775
-6,928
-37% -$1.13M ﹤0.01% 1316
2025
Q3
$2.62M Sell
18,703
-396
-2% -$53.5K 0.01% 1193
2025
Q2
$2.4M Buy
19,099
+1,158
+6% +$144K 0.01% 1132
2025
Q1
$2.46M Buy
17,941
+5,620
+46% +$803K 0.01% 1076
2024
Q4
$1.88M Sell
12,321
-1,218
-9% -$205K 0.01% 1181
2024
Q3
$2.63M Sell
13,539
-1,387
-9% -$290K 0.01% 1014
2024
Q2
$3.46M Sell
14,926
-1,044
-7% -$227K 0.01% 855
2024
Q1
$3.44M Sell
15,970
-954
-6% -$223K 0.01% 905
2023
Q4
$4.38M Sell
16,924
-1,348
-7% -$331K 0.01% 789
2023
Q3
$4.7M Sell
18,272
-12,277
-40% -$3.28M 0.02% 695
2023
Q2
$8.7M Buy
30,549
+11,871
+64% +$3.53M 0.03% 515
2023
Q1
$5.19M Sell
18,678
-120
-0.6% -$33.2K 0.02% 631
2022
Q4
$5.21M Sell
18,798
-5,392
-22% -$1.52M 0.02% 657
2022
Q3
$6.46M Sell
24,190
-2,770
-10% -$588K 0.03% 526
2022
Q2
$5.48M Sell
26,960
-5,298
-16% -$1.08M 0.02% 573
2022
Q1
$6.79M Buy
32,258
+4,715
+17% +$1.03M 0.03% 491
2021
Q4
$6.61M Sell
27,543
-2,251
-8% -$579K 0.03% 535
2021
Q3
$8.43M Buy
29,794
+101
+0.3% +$33.1K 0.04% 425
2021
Q2
$10.3M Sell
29,693
-2,808
-9% -$851K 0.05% 356
2021
Q1
$9.09M Buy
32,501
+884
+3% +$238K 0.04% 351
2020
Q4
$7.74M Buy
31,617
+927
+3% +$239K 0.04% 400
2020
Q3
$8.71M Sell
30,690
-903
-3% -$252K 0.05% 323
2020
Q2
$8.45M Sell
31,593
-875
-3% -$263K 0.05% 315
2020
Q1
$10.3M Sell
32,468
-1,128
-3% -$342K 0.08% 244
2019
Q4
$9.97M Sell
33,596
-3,045
-8% -$845K 0.07% 285
2019
Q3
$8.53M Sell
36,641
-519
-1% -$121K 0.06% 312
2019
Q2
$8.69M Sell
37,160
-10,578
-22% -$2.44M 0.07% 293
2019
Q1
$11.3M Sell
47,738
-1,162
-2% -$366K 0.09% 244
2018
Q4
$14.7M Sell
48,900
-1,722
-3% -$550K 0.14% 164
2018
Q3
$17.9M Buy
50,622
+5,431
+12% +$1.87M 0.15% 146
2018
Q2
$13.1M Buy
45,191
+8,229
+22% +$2.31M 0.13% 188
2018
Q1
$10.1M Buy
36,962
+487
+1% +$151K 0.1% 224
2017
Q4
$11.6M Buy
36,475
+725
+2% +$233K 0.12% 200
2017
Q3
$11.2M Sell
35,750
-752
-2% -$223K 0.13% 189
2017
Q2
$9.9M Buy
36,502
+2,673
+8% +$707K 0.12% 200
2017
Q1
$9.25M Buy
33,829
+1,058
+3% +$299K 0.12% 202
2016
Q4
$9.29M Buy
32,771
+4,726
+17% +$1.4M 0.14% 181
2016
Q3
$8.78M Buy
+28,045
New +$8.31M 0.15% 158
2016
Q2
Sell
-25,422
Closed -$6.62M 714
2016
Q1
$6.62M Buy
25,422
+11,297
+80% +$2.98M 0.17% 139
2015
Q4
$4.33M Buy
14,125
+160
+1% +$46K 0.11% 202
2015
Q3
$4.08M Buy
13,965
+892
+7% +$295K 0.12% 204
2015
Q2
$5.28M Buy
13,073
+713
+6% +$286K 0.11% 234
2015
Q1
$5.22M Buy
12,360
+692
+6% +$273K 0.1% 257
2014
Q4
$3.96M Buy
11,668
+1,690
+17% +$547K 0.08% 300
2014
Q3
$3.3M Buy
9,978
+135
+1% +$44.5K 0.07% 362
2014
Q2
$3.1M Buy
9,843
+4,698
+91% +$1.41M 0.07% 356
2014
Q1
$1.57M Sell
5,145
-63
-1% -$20K 0.04% 555
2013
Q4
$1.46M Buy
5,208
+289
+6% +$74.8K 0.04% 563
2013
Q3
$1.18M Buy
+4,919
New +$1.1M 0.04% 577

Other funds holding BIIB

Janney Montgomery Scott's BIIB Position: Q1 2026 in Review

Janney Montgomery Scott sold out of Biogen (BIIB) in Q1 2026, closing a stake of 11,775 shares — an estimated $2.07M sold.

Janney Montgomery Scott first reported a position in BIIB in Q3 2013 and held it in 49 quarters. The position peaked at $17.9M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Janney Montgomery Scott reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Janney Montgomery Scott sold 11,775 Biogen shares in Q1 2026, an estimated $2.07M.
  • Janney Montgomery Scott first reported a position in Biogen in Q3 2013 and held it in 49 quarters.
  • Janney Montgomery Scott's Biogen position peaked at $17.9M in Q3 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.